CRP and osteoarthritis, knee: A randomised double-blind, placebo-controlled clinical trial assessing the effect of Lacticaseibacillus casei Shirota (LcS) in patients with knee osteoarthritis reported that knee pain improved and circulating levels of C-reactive protein decreased, leading the authors to conclude that LcS consumption could improve the outcome of knee OA, by reducing inflammatory responses [6].